Gold nanoparticles as novel agents for cancer therapy

Area of Science:

• Nanotechnology
• Materials Science
• Oncology

Background:

• Gold nanoparticles (AuNPs) are increasingly explored for diverse cancer therapy applications.
• These applications include drug delivery, photothermal therapy, imaging contrast agents, and radiosensitization.
• Recent advancements have propelled AuNP research into early-phase clinical trials.

Purpose of the Study:

• To provide an overview of nanotechnology in cancer therapy.
• To focus on recent gold nanoparticle research and its clinical translation.
• To review pre-clinical evidence of AuNPs as radiosensitizers.

Main Methods:

• Literature review of nanotechnology and gold nanoparticle research.
• Analysis of pre-clinical data on AuNPs in combination with ionizing radiation.
• Discussion of studies conducted at both kilovoltage and megavoltage radiation energies.

Main Results:

• Gold nanoparticles demonstrate potential as radiosensitizers in pre-clinical cancer models.
• Evidence supports their efficacy both in vitro and in vivo.
• The sensitizing effect is observed across different radiation energy levels.

Conclusions:

• Gold nanoparticles represent a promising tool in radiation oncology.
• Further pre-clinical validation supports their role in enhancing cancer treatment efficacy.
• The progression to clinical trials underscores the therapeutic potential of AuNPs.